Mesothelioma | Tumor

CURE’s mesothelioma page is a go-to resource for oncology news and updates in the world of mesothelioma Here, readers will find cancer articles, videos, podcasts, and more with expert insight to the latest treatments and research in mesothelioma.

Having Cancer Taught Me About Self Advocacy

November 3rd 2022, 5:00pm

Article

After being diagnosed with mesothelioma, I learned to advocate for myself, and realized that it was an incredibly important life skill to have.

5 Things Cancer Taught Me About Mental Health

October 3rd 2022, 5:00pm

Article

I grew up in a society where mental health was stigmatized, but cancer made me realize that it helps to speak up about these issues.

Summer Travel Amid Cancer/COVID-19 Concerns: Are You in or Out?

August 26th 2022, 6:00pm

Article

After being homebound for two years from the COVID-19 pandemic, I was eager to get out, though I did have many cancer/COVID-19 concerns.

Majority of Patients with Mesothelioma Subtype Responded to Keytruda-Lenvima Combo

August 24th 2022, 1:00pm

Article

Patients with malignant pleural mesothelioma tended to have prolonged benefit when treated with Keytruda plus Lenvima in the PEMMELA clinical trial.

My Story of Hope After Being Diagnosed With a Cancer I’ve Never Heard Of

July 29th 2022, 5:00pm

Article

I don’t fit the profile of someone who gets diagnosed with mesothelioma, so my diagnosis came as a shock.

FDA to Speed Up Review of Novel Drug for Mesothelioma Not Treatable by Surgery

June 28th 2022, 3:00pm

Article

The FDA plans to accelerate its review of IK-930, an investigational drug, for the treatment of patients with unresectable NF2-deficient malignant pleural mesothelioma, a rare cancer.

Expansion of IOA-244 Trial Fully Enrolled for Uveal Melanoma

November 26th 2021, 10:00pm

Article

Part B of the DIONE-01 study will look at whether IOA-244 increases anti-tumor responses in expansion groups of patients.

Imfinzi-Chemo Combo Improves Survival for Mesothelioma

November 16th 2021, 10:00pm

Article

Imfinzi plus platinum-pemetrexed chemotherapy induced survival improvements in patients with previously untreated, unresectable malignant pleural mesothelioma, compared with chemotherapy alone.

Opdivo May Improve Survival in Mesothelioma That Progressed on First-Line Chemotherapy

October 26th 2021, 3:00pm

Article

Treatment with the immunotherapy Opdivo for relapsed, malignant mesothelioma may represent a useful choice for patients with minimal therapy options.

COVID-19 Increases Death, Hospitalization Rates in Patients With Mesothelioma

September 20th 2021, 3:00pm

Article

The average survival for patients with malignant pleural mesothelioma was less than a month after being diagnosed with COVID-19, according to a small study.